More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to measure their glucose levels could be a step closer thanks to a Monash University-led project.
The researchers from Monash University, RMIT University, The University of Melbourne and the Baker Institute developed the system to respond to glucose, which current insulin does not.
Co-first author Dr. Rong Xu, from the Monash University Central Clinical School’s Australian Center for Blood Diseases, and Dr. Sukhvir Kaur Bhangu from RMIT University and the University of Melbourne said if it worked in humans, only two injections would be needed per day.
Current insulin therapy requires people to monitor their blood sugar throughout the day and take multiple, carefully calculated doses based on food intake, exercise, stress, illness and other factors.
Some must inject themselves up to five times a day. Continuous glucose monitoring devices remove, or at least reduce, the need for finger pricks, and insulin pumps can automatically deliver insulin, but they are very expensive and still are not always able to calculate the correct amount of insulin to be given.
The multidisciplinary team developed a new “artificial pancreas system” using phytoglycogen nanoparticles, which are chains on glucose molecules dubbed a “nanosugar platform” as they are made of glucose, to deliver and release insulin in response to glucose levels in the blood.
This engineered nanosugar platform enabled rapid and sustained glucose-responsive insulin delivery, which was longer lasting and smarter than other systems.
Dr. Xu said it required only one injection every 12 hours and self-regulated. “This system would mean fewer injections and, potentially, no need to measure glucose,” Dr. Xu said.
The research emerged from an NHMRC Ideas Grant awarded to co-lead author and Head of Monash University’s Australian Center for Blood Diseases NanoBiotechnology Laboratory, Professor Christoph Hagemeyer, co-lead author and RMIT Associate Professor Francesca Cavalieri, and co-author Professor Frank Caruso at the University of Melbourne to develop this revolutionary type of insulin.
Professor Hagemeyer said more research was needed but the results were promising. He said the nanosugar platform was biodegradable, which enabled rapid and extended glucose control in two different models of type 1 diabetes with a single injection.
“The nanosugar particles are engineered to control insulin release and absorption through the lymphatic system into the blood,” he said.
Professor Cavalieri said the research team, which includes several clinicians, now hoped to secure funding to continue the project and eventually undertake clinical trials. “This new method is not only efficient, it’s biodegradable and uses natural methods, which significantly reduces the chances of adverse affects or immune reactions,” she said.
News
How the FDA opens the door to risky chemicals in America’s food supply
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are [...]
Superbug crisis could get worse, killing nearly 40 million people by 2050
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them could increase nearly 70% by 2050, a new study projects, further showing the [...]
How Can Nanomaterials Be Programmed for Different Applications?
Nanomaterials are no longer just small—they are becoming smart. Across fields like medicine, electronics, energy, and materials science, researchers are now programming nanomaterials to behave in intentional, responsive ways. These advanced materials are designed [...]
Microplastics Are Invading Our Arteries, and It Could Be Increasing Your Risk of Stroke
Higher levels of micronanoplastics were found in carotid artery plaque, especially in people with stroke symptoms, suggesting a potential new risk factor. People with plaque buildup in the arteries of their neck have been [...]
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging [...]
Engineered extracellular vesicles facilitate delivery of advanced medicines
Graphic abstract of the development of VEDIC and VFIC systems for high efficiency intracellular protein delivery in vitro and in vivo. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59377-y. https://www.nature.com/articles/s41467-025-59377-y Researchers at Karolinska Institutet have developed a technique [...]
Brain-computer interface allows paralyzed users to customize their sense of touch
University of Pittsburgh School of Medicine scientists are one step closer to developing a brain-computer interface, or BCI, that allows people with tetraplegia to restore their lost sense of touch. While exploring a digitally [...]
Scientists Flip a Gut Virus “Kill Switch” – Expose a Hidden Threat in Antibiotic Treatment
Scientists have long known that bacteriophages, viruses that infect bacteria, live in our gut, but exactly what they do has remained elusive. Researchers developed a clever mouse model that can temporarily eliminate these phages [...]
Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressing
Background Wound healing is a complex physiological process that can be compromised by infection and impaired tissue regeneration. Conventional dressings, typically made from natural fibers such as cotton or linen, offer limited functionality. Nanofiber [...]
Global Nanomaterial Regulation: A Country-by-Country Comparison
Nanomaterials are materials with at least one dimension smaller than 100 nanometres (about 100,000 times thinner than a human hair). Because of their tiny size, they have unique properties that can be useful in [...]
Pandemic Potential: Scientists Discover 3 Hotspots of Deadly Emerging Disease in the US
Virginia Tech researchers discovered six new rodent carriers of hantavirus and identified U.S. hotspots, highlighting the virus’s adaptability and the impact of climate and ecology on its spread. Hantavirus recently drew public attention following reports [...]
Studies detail high rates of long COVID among healthcare, dental workers
Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that the percentage is much higher among healthcare workers [...]
Melting Arctic Ice May Unleash Ancient Deadly Diseases, Scientists Warn
Melting Arctic ice increases human and animal interactions, raising the risk of infectious disease spread. Researchers urge early intervention and surveillance. Climate change is opening new pathways for the spread of infectious diseases such [...]
Scientists May Have Found a Secret Weapon To Stop Pancreatic Cancer Before It Starts
Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage pancreatic cancer from progressing, offering a promising path toward prevention. Pancreatic cancer is expected to become [...]
Breakthrough Drug Restores Vision: Researchers Successfully Reverse Retinal Damage
Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one of the most important human senses, yet more than 300 million people around the world are at [...]
Differentiating cancerous and healthy cells through motion analysis
Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy. They observed malignant fibrosarcoma [...]
